Skip to main content

Published locations for Response endures in cemiplimab-treated patients with cutaneous SCC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Response endures in cemiplimab-treated patients with cutaneous SCC

User login

  • Reset your password
  • /content/response-endures-cemiplimab-treated-patients-cutaneous-scc
  • /edermatologynews/article/202968/nonmelanoma-skin-cancer/response-endures-cemiplimab-treated-patients
  • /oncologypractice/article/202968/nonmelanoma-skin-cancer/response-endures-cemiplimab-treated-patients
  • /hematology-oncology/article/202968/nonmelanoma-skin-cancer/response-endures-cemiplimab-treated
  • /dermatology/article/202968/nonmelanoma-skin-cancer/response-endures-cemiplimab-treated-patients